Preclinical / Nonclinical
Preclinical (nonclinical) development refers to the process through which investigational drugs are subjected to extensive laboratory testing to determine their safety for humans.
At Woodley BioReg, our team of industry and agency-experienced consultants can support you every step of the way — from defining your Target Product Profile (TPP) and preclinical / nonclinical development, through to licence submission, approval and maintenance.
With our combined expertise spanning many decades, we can help to develop and refine your regulatory and quality strategies to ensure a smooth and speedy journey to get your pharmaceutical products to market efficiently.
And, with our insight into the ways in which regulatory agencies operate around the world, we can assist you in planning for success, right from the start.
Discover all of the services that we offer to clients operating in the pharmaceutical sphere below.